Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Vaccination site pain
Clinical narrative: experienced metallic taste in mouth; sore arm at injection site; This is a spontaneous report from non-contactable consumer via Pfizer Sales Representative. This 57-year-old female consumer reported for herself that:  Reporter Name: (name-withheld) Reported by: Consumer Reporter Contact Information: Dont know Patient Name: (name-withheld)  Description of Event: 57 yo F, experienced metallic taste in mouth that went away quickly and sore arm at injection site that went away next day  Optional Information: Event took place shortly after 1st dose Synthroid  Name of Product: COVID Vaccine Awareness Date: 30Mar2021 Country of Occurrence:  Event took place after use of product.  Follow-up(23May2021): This is a follow-up spontaneous report from non-contactable consumer via Pfizer Sales Representative. This consumer reported for herself that:  Reporter Name: Consumer Reported by: Consumer Reporter Contact Information: Dont know Patient Name: (name-withheld) Description of Event: 56 yo female about 5ft 2 in  Pt experienced big yellow circle mark at injection site following 2nd dose and now has various bruising on arms/forearms which she says she did not have before vaccine 2nd dose in April  Optional Information: Hypothyroidism on synthroid, diabetes  Name of Product: COVID vaccine Awareness Date: 23May2021 Country of Occurrence:  Event took place after use of product.  No follow up attempts are possible. Information about lot/batch number cannot be requested. No further information is expected. This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 57 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "diabetes" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID taken for hypothyroidism. The following information was reported: DYSGEUSIA (non-serious) with onset 30Mar2021, outcome "unknown", described as "experienced metallic taste in mouth"; VACCINATION SITE PAIN (non-serious) with onset 30Mar2021, outcome "unknown", described as "sore arm at injection site". This is a spontaneous report received from non-contactable reporter (Consumer) from a sales representative. The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 57 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "diabetes" (unspecified if ongoing). Concomitant medication included: SYNTHROID taken for hypothyroidism. The following information was reported: DYSGEUSIA (non-serious) with onset 30Mar2021, outcome "unknown", described as "experienced metallic taste in mouth"; VACCINATION SITE PAIN (non-serious) with onset 30Mar2021, outcome "unknown", described as "sore arm at injection site".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.